Open AccessClinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms
Author(s) -
Qiong Lu,
Guohua Li,
Qiang Qu,
Haihong Zhu,
Yue Luo,
Yaling Han,
Hao Yuan,
Jian Qu
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s312708
Subject(s) - medicine , polymyxin , clinical efficacy , adverse effect , polymyxin b , cumulative dose , mechanical ventilation , gastroenterology , logistic regression , antibiotics , biology , microbiology and biotechnology
Carbapenem-resistant organisms (CROs) pose great challenges for clinical treatment. Polymyxin B (PMB) is one of the "last resort" choices of CRO infections. We explored the possible factors affecting PMB efficacy.